MTS Medication Tech. (MTSI) Tops Q4 Views
MTS Medication Technologies, Inc. (NASDAQ: MTSI) reports Q4 EPS of $0.13, 4 cents better than the analyst estimate of $0.09. Revenue for the quarter was $17 million, versus the consensus of $16.60 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
